Human IVD | Colloidal Gold Immunochromatography
COVID-19 & Influenza A+B Antigen Combo Rapid Test
COVID-19 & Influenza A+B Antigen Combo Rapid Test uses colloidal gold immunochromatography for rapid qualitative detection of COVID-19 & Influenza A+B Antigen Combo. Campione: nasal, nasopharyngeal or oropharyngeal swab. Formatoo confezione: 25 tests/box.
25 tests/box
10-15 min
2-30°C
Caratteristiche del prodotto
Clear C/T line interpretation
Colloidal gold lateral-flow design enables direct visual reading for clinics, laboratories and field screening.
Validated specimen workflow
The assay workflow is aligned to whole blood, serum, plasma, swab or stool specimens according to the product type.
Distributor-ready packaging
Human rapid tests are configured as 25 tests/box for professional, channel and batch-testing needs.
International IVD presentation
Individually pouched cassettes, buffer, disposable sampling accessories and IFU support storage and traceability.
Specifiche tecniche
- Uso previsto
- Rapid qualitative detection of COVID-19 & Influenza A+B Antigen Combo in human specimens.
- Metodo
- Colloidal gold immunochromatographic assay
- Formato
- Multi-panel rapid test cassette
- Target analyte
- COVID-19 & Influenza A+B Antigen Combo
- Campione
- nasal, nasopharyngeal or oropharyngeal swab
- Tempo di lettura
- 10-15 minutes
- Conservazione
- 2-30°C, dry and away from direct light
- Shelf life
- 24 months, subject to the registered IFU
- Formatoo confezione
- 25 tests/box
- Kit components
- 25 individually pouched test cassettes, sample buffer, droppers/swabs/sampling accessories, IFU
- Use
- Professional in vitro diagnostic use